DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Kondagunta GV, Hudes GR, Figlin R, Wilding G, Hariharan S, Kempin SN, Fayyad R, Hoosen S, Motzer RJ.
Sunitinib malate (SU) plus interferon (IFN) in first line
metastatic renal cell cancer (mRCC): Results of a dose-finding study.
J Clin Oncol 2007; 25
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.